An Open-Label, Multicentre, Phase Iiib Study With Intravenous Administration Of Pertuzumab, Subcutaneous Trastuzumab, And A Taxane In Patients With Her2-Positive Metastatic Breast Cancer (Sapphire)
CANCER RESEARCH（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要